Cargando…
二线及以上应用贝伐珠单抗联合化疗治疗晚期非鳞非小细胞肺癌的疗效及安全性观察
BACKGROUND AND OBJECTIVE: Bevacizumab combined with platinum-based chemotherapy has been recommended as the first-line agent in advanced nonsquamous non-small cell lung cancer (NSCLC) without driven gene, but this regimen is not common in the second-line or later-line treatment of non-squamous NSCLC...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058654/ https://www.ncbi.nlm.nih.gov/pubmed/30037370 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.02 |